UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Human memory FOXP3⁺ Tregs secrete IL-17 ex vivo and constitutively express the TH17 lineage-specific transcription factor RORγt

Proceedings of the National Academy of Sciences - PNAS, 2009-05, Vol.106 (21), p.8635-8640

2009

Volltextzugriff (PDF)

Modulation of Cytokine Secretion Allows CD4 T Cells Secreting IL-10 and IL-17 to Simultaneously Participate in Maintaining Tolerance and Immunity

PloS one, 2015-12, Vol.10 (12), p.e0145788-e0145788

2015

Volltextzugriff (PDF)

Immune Responses to the Cancer Testis Antigen XAGE-1b in Non Small Cell Lung Cancer Caucasian Patients

PloS one, 2016-03, Vol.11 (3), p.e0150623-e0150623

2016

Volltextzugriff (PDF)

Correction: Immune Responses to the Cancer Testis Antigen XAGE-1b in Non Small Cell Lung Cancer Caucasian Patients

PloS one, 2016-07, Vol.11 (7), p.e0160538-e0160538

2016

Volltextzugriff (PDF)

A peripheral circulating compartment of natural naive CD4 Tregs

The Journal of clinical investigation, 2005-07, Vol.115 (7), p.1953-1962

2005

Volltextzugriff (PDF)

Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming

Proceedings of the National Academy of Sciences - PNAS, 2007-05, Vol.104 (21), p.8947-8952

2007

Volltextzugriff (PDF)

Recombinant Vaccinia/Fowlpox NY-ESO-1 Vaccines Induce Both Humoral and Cellular NY-ESO-1-Specific Immune Responses in Cancer Patients

Proceedings of the National Academy of Sciences - PNAS, 2006-09, Vol.103 (39), p.14453-14458

2006

Volltextzugriff (PDF)

BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth

The Journal of experimental medicine, 1999-06, Vol.189 (11), p.1747-1756

1999

Volltextzugriff (PDF)

Monitoring of NY-ESO-1 specific CD4⁺ T cells using molecularly defined MHC class II/His-tag-peptide tetramers

Proceedings of the National Academy of Sciences - PNAS, 2010-04, Vol.107 (16), p.7437-7442

2010

Volltextzugriff (PDF)

Assessment of MAGE-A expression in resected non-small cell lung cancer in relation to clinicopathologic features and mutational status of EGFR and KRAS

Cancer immunology research, 2014-10, Vol.2 (10), p.943-948

2014

Volltextzugriff (PDF)

MHC class II/ESO tetramer-based generation of in vitro primed anti-tumor T-helper lines for adoptive cell therapy of cancer

Haematologica (Roma), 2013-02, Vol.98 (2), p.316-322

2013

Volltextzugriff (PDF)

Antibody responses to NY-ESO-1 in primary breast cancer identify a subtype target for immunotherapy

PloS one, 2011-06, Vol.6 (6), p.e21129-e21129

2011

Volltextzugriff (PDF)

Human RORγt⁺ TH17 cells preferentially differentiate from naive FOXP3⁺Treg in the presence of lineage-specific polarizing factors

Proceedings of the National Academy of Sciences - PNAS, 2010-11, Vol.107 (45), p.19402-19407

2010

Volltextzugriff (PDF)

Vaccination with Recombinant NY-ESO-1 Protein Elicits Immunodominant HLA-DR52b-restricted CD4+ T Cell Responses with a Conserved T Cell Receptor Repertoire

Clinical cancer research, 2009-07, Vol.15 (13), p.4467-4474

2009

Volltextzugriff (PDF)

NY-ESO-1-specific circulating CD4+ T cells in ovarian cancer patients are prevalently T(H)1 type cells undetectable in the CD25+ FOXP3+ Treg compartment

PloS one, 2011, Vol.6 (7), p.e22845-e22845

2011

Volltextzugriff (PDF)

Comment on "differentiation of IL-17-producing effector and regulatory human T cells from lineage-committed naive precursors"

The Journal of immunology (1950), 2014-10, Vol.193 (7), p.3181-3181

2014

Volltextzugriff (PDF)

CXCR3+ T Regulatory Cells Selectively Accumulate in Human Ovarian Carcinomas to Limit Type I Immunity

Cancer research (Chicago, Ill.), 2012-09, Vol.72 (17), p.4351-4360

2012

Volltextzugriff (PDF)

HLA Class I–Associated Immunodominance Affects CTL Responsiveness to an ESO Recombinant Protein Tumor Antigen Vaccine

Clinical cancer research, 2009-01, Vol.15 (1), p.299-306

2009

Volltextzugriff (PDF)

Proteasome-Assisted Identification of a SSX-2-Derived Epitope Recognized by Tumor-Reactive CTL Infiltrating Metastatic Melanoma

The Journal of immunology (1950), 2002-02, Vol.168 (4), p.1717-1722

2002

Volltextzugriff (PDF)

Differential Presentation of a Soluble Exogenous Tumor Antigen, NY-ESO-1, by Distinct Human Dendritic Cell Populations

Proceedings of the National Academy of Sciences - PNAS, 2002-08, Vol.99 (16), p.10629-10634

2002

Volltextzugriff (PDF)

Cross‐presentation of NY‐ESO‐1 cytotoxic T lymphocyte epitope fused to human heat shock cognate protein 70 by dendritic cells

Cancer science, 2008-01, Vol.99 (1), p.107-112

2008

Volltextzugriff (PDF)

IL-1β and IL-2 convert human Treg into TH17 cells

Clinical immunology (Orlando, Fla.), 2009-05, Vol.131 (2), p.298-307

2009

Volltextzugriff (PDF)

Expression of Synovial Sarcoma X (SSX) Antigens in Epithelial Ovarian Cancer and Identification of SSX-4 Epitopes Recognized by CD4+ T Cells

Clinical cancer research, 2006-01, Vol.12 (2), p.398-404

2006

Volltextzugriff (PDF)

CD4+ T helper cell responses to NY-ESO-1 tumor antigen in ovarian cancer resist perversion into immunosuppressive Tregs

Oncoimmunology, 2015-12, Vol.4 (12), p.e946370-e946370

2015

Volltextzugriff (PDF)

Prospective strategies to combine conventional, targeted and immunotherapies in non-small cell lung cancer

Oncoimmunology, 2016-04, Vol.5 (4), p.e947175-e947175

2016

Volltextzugriff (PDF)

1 – 25 von 178

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(173)
Mit Volltextzugriff
(171)

Publikationsform

Artikel
(177)
Buchkapitel
(1)

Sprache

Englisch
(178)

Erscheinungsjahr

n.n

Thema

Humans
(121)
Science & Technology
(115)
Life Sciences & Biomedicine
(106)
Immunology
(80)
Antigens, Neoplasm - Immunology
(53)
Biological And Medical Sciences
(45)
T-Lymphocytes, Cytotoxic - Immunology
(45)
Melanoma - Immunology
(43)
Neoplasm Proteins - Immunology
(43)
Amino Acid Sequence
(37)
Oncology
(36)
Medical Sciences
(35)
Peptide Fragments - Immunology
(33)
Cd8-Positive T-Lymphocytes - Immunology
(32)
Mart-1 Antigen
(30)
Molecular Sequence Data
(29)
Animals
(27)
Immunotherapy
(26)
Epitopes, T-Lymphocyte - Immunology
(24)
Tumors
(23)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Human memory FOXP3⁺ Tregs secrete IL-17 ex vivo and constitutively express the TH17 lineage-specific transcription factor RORγt

Modulation of Cytokine Secretion Allows CD4 T Cells Secreting IL-10 and IL-17 to Simultaneously Participate in Maintaining Tolerance and Immunity

Immune Responses to the Cancer Testis Antigen XAGE-1b in Non Small Cell Lung Cancer Caucasian Patients

Correction: Immune Responses to the Cancer Testis Antigen XAGE-1b in Non Small Cell Lung Cancer Caucasian Patients

A peripheral circulating compartment of natural naive CD4 Tregs

Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming

Recombinant Vaccinia/Fowlpox NY-ESO-1 Vaccines Induce Both Humoral and Cellular NY-ESO-1-Specific Immune Responses in Cancer Patients

BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth

Monitoring of NY-ESO-1 specific CD4⁺ T cells using molecularly defined MHC class II/His-tag-peptide tetramers

Assessment of MAGE-A expression in resected non-small cell lung cancer in relation to clinicopathologic features and mutational status of EGFR and KRAS

MHC class II/ESO tetramer-based generation of in vitro primed anti-tumor T-helper lines for adoptive cell therapy of cancer

Antibody responses to NY-ESO-1 in primary breast cancer identify a subtype target for immunotherapy

Human RORγt⁺ TH17 cells preferentially differentiate from naive FOXP3⁺Treg in the presence of lineage-specific polarizing factors

Vaccination with Recombinant NY-ESO-1 Protein Elicits Immunodominant HLA-DR52b-restricted CD4+ T Cell Responses with a Conserved T Cell Receptor Repertoire

NY-ESO-1-specific circulating CD4+ T cells in ovarian cancer patients are prevalently T(H)1 type cells undetectable in the CD25+ FOXP3+ Treg compartment

Comment on "differentiation of IL-17-producing effector and regulatory human T cells from lineage-committed naive precursors"

CXCR3+ T Regulatory Cells Selectively Accumulate in Human Ovarian Carcinomas to Limit Type I Immunity

HLA Class I–Associated Immunodominance Affects CTL Responsiveness to an ESO Recombinant Protein Tumor Antigen Vaccine

Proteasome-Assisted Identification of a SSX-2-Derived Epitope Recognized by Tumor-Reactive CTL Infiltrating Metastatic Melanoma

Differential Presentation of a Soluble Exogenous Tumor Antigen, NY-ESO-1, by Distinct Human Dendritic Cell Populations

Cross‐presentation of NY‐ESO‐1 cytotoxic T lymphocyte epitope fused to human heat shock cognate protein 70 by dendritic cells

IL-1β and IL-2 convert human Treg into TH17 cells

Expression of Synovial Sarcoma X (SSX) Antigens in Epithelial Ovarian Cancer and Identification of SSX-4 Epitopes Recognized by CD4+ T Cells

CD4+ T helper cell responses to NY-ESO-1 tumor antigen in ovarian cancer resist perversion into immunosuppressive Tregs

Prospective strategies to combine conventional, targeted and immunotherapies in non-small cell lung cancer

Suchergebnisse filtern